ORION PHARMA A/S — Credit Rating and Financial Key Figures

ORION PHARMA A/S (CVR number: 20601116) is a company from KØBENHAVN. The company reported a net sales of 309 mDKK in 2024, demonstrating a growth of 22.1 % compared to the previous year. The operating profit percentage was at 4.1 % (EBIT: 12.8 mDKK), while net earnings were 10.9 mDKK. The profitability of the company measured by Return on Assets (ROA) was 17.4 %, which can be considered excellent and Return on Equity (ROE) was 26.1 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 45.4 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. ORION PHARMA A/S's liquidity measured by quick ratio was 1.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.